Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis.
about
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug usersExposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: implications for chemotherapy against mycobacterial persistorsEvaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patientsRelationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaBactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcomeTests for bactericidal effects of antimicrobial agents: technical performance and clinical relevanceClinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.Responses of tolerant and nontolerant Staphylococcus aureus strains to methicillin treatment in an experimental infection in micePenicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and nontolerant Streptococcus mitisDetermination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.pH-dependent oxacillin tolerance of Staphylococcus aureus.Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis.Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus.Non-inherited antibiotic resistance.Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers.Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.Detection of penicillin tolerance in streptococci.Antibiotic tolerance among clinical isolates of bacteria.Problems in in vitro determination of antibiotic tolerance in clinical isolates.In vitro studies of investigational beta-lactams as possible therapy for Pseudomonas aeruginosa endocarditisLack of reproducibility of macrodilution MBCs for Staphylococcus aureus.Evaluation of oxacillin tolerance in Staphylococcus aureus by a novel method.Variables in demonstrating methicillin tolerance in Staphylococcus aureus strainsScreening for penicillin tolerance in viridans streptococci by a simple disk method.Basic mechanisms of bacterial tolerance of antimicrobial agents.Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy.Tolerance percentage as a criterion for the detection of tolerant Staphylococcus aureus strains.Activity of nine antimicrobial agents against Lancefield group C and group G streptococci.Comparison of in vivo and in vitro activities of antibiotics with different modes of action against a tolerant and a non-tolerant Staphylococcus aureus strain.Comparison of the effectiveness of various antibiotics in the treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis.
P2860
Q24675979-F82BD068-050E-4485-9102-4EBAEF03F92AQ28487060-E98CC031-BEE5-4B25-A5EA-ED50B635457BQ33742289-3FAE58A9-194C-40A8-A3D6-09BC6E423151Q34783668-9AAC2AFE-D693-4CC1-B66E-E70CAD3DA187Q35078077-897DAC5A-75D9-42D4-B856-C9621861DAF1Q35474824-024C2126-05DD-4290-95A4-50B76B2B18DFQ35536476-F571C726-A08C-4AA4-B943-FAE5C79F5589Q35640985-FFC8047D-05A6-4552-8DA3-6AD70D465B19Q35739753-2947C62A-AD3E-4291-9B09-20866B3BA2FAQ35745822-CC99FA2D-115F-44D5-AC65-5EEA84F72D54Q35769520-9C1FC8C9-8DBA-4A77-A5C9-A96E81752CC8Q35769882-32519642-20D4-4BC8-A172-FA70C1CA2175Q35820407-6F56BCEB-27CF-4636-BFD8-658B1B352622Q36508695-780D3BB9-4DB7-4CD6-AA98-FF7299914FAFQ37022592-570A83E8-D062-4E5E-997B-40F935EE7023Q38780029-164F6DC7-D528-49D0-89B0-633CF73C6695Q39520607-6413E0D5-5A95-451B-993B-298C6538AC4FQ39750871-77610FED-31DE-4AA6-BB23-53E13C755025Q39753950-1E6BBAE3-828C-4022-8023-05FE82B4AC58Q39833604-C6BE7FF3-789C-43B7-AE9A-49D7DE77F6A9Q39849397-5F888846-926B-42CE-9AC5-92092634C150Q39850270-8A025656-827E-40FE-BFC6-FE94E47CE5E2Q39856926-7CEAE7E6-ED17-4478-B3A1-1CC7AD436B62Q40225123-02731153-8E4B-44F0-BDCF-D1BD4DB389B9Q40486457-15EDEE10-E6C2-49E0-A8A2-83F63A8000BAQ40690496-E57B2151-7A85-4768-A629-696DFD2FAC4AQ42929868-027DD487-F52D-46C7-B810-FC6CF888C542Q42930002-36321074-E6E3-4A71-89E8-5D005CBAD4C4Q43451460-CF01784F-B22F-4811-B300-7E700319998FQ44055508-0533CF06-607F-483E-80C6-B59894872640
P2860
Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Clinical significance of toler ...... in patients with endocarditis.
@en
type
label
Clinical significance of toler ...... in patients with endocarditis.
@en
prefLabel
Clinical significance of toler ...... in patients with endocarditis.
@en
P2093
P1476
Clinical significance of toler ...... in patients with endocarditis.
@en
P2093
Kallick CA
Rajashekaraiah KR
Ramakrishna B
P304
P356
10.7326/0003-4819-93-6-796
P407
P577
1980-12-01T00:00:00Z